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Abstract
Caffeine enhances cognition, but even high non-physiological doses have modest effects on 
synapses. A1 adenosine receptors (A1Rs) are antagonized by caffeine and are most highly enriched 
in hippocampal CA2, which has not been studied in this context. Here we show that physiological 
doses of caffeine in vivo or A1R antagonists in vitro induce robust, long-lasting potentiation of 
synaptic transmission in rat CA2 without effect in other regions of the hippocampus.
Caffeine is a widely-used naturally-occurring cognitive enhancer, yet none of its effects on 
synaptic transmission described thus far are overt. The effects of caffeine on cognition are 
mediated primarily by blockade of the A1 adenosine receptor (A1R), and antagonists of 
A1Rs enhance induction and stability of long-term potentiation (LTP) in hippocampal 
CA11,2. A1Rs, though, are most highly enriched in CA23, suggesting a unique role for this 
region in mediating the effects of caffeine. Schaffer collateral synapses in CA2 differ 
significantly from others in the hippocampus in that they enigmatically fail to exhibit 
activity-dependent LTP4 due largely to higher calcium buffering and extrusion, and presence 
of RGS14 in CA2 pyramidal neurons5,6. We therefore examined whether caffeine 
differentially influences synaptic strength in CA2. To do this, we prepared hippocampal 
slices from juvenile rats one hour after they had been orally administered one of three doses 
of caffeine representing different levels of human use: 2 mg/kg, or two large cups of coffee; 
6.5 mg/kg, one highly-caffeinated energy drink; or 20 mg/kg, a dose that exceeds most 
people’s daily intake. Regardless of dose, caffeine induced a persistent and significant 
increase in synaptic responses in CA2, but not in CA1 (Fig. 1a–f). Additionally, neuronal 
excitability was unaffected by caffeine (Fig. 1g–i), suggesting that the enhanced 
transmission in CA2 was due to modifications at synapses. Although previous studies have 
shown that adenosine antagonists modulate LTP induction1,7, this is the first demonstration 
of long-lasting plasticity induced solely by in vivo exposure to caffeine. As important, these 
data identify synapses in CA2 as a target of caffeine.
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To control for possible indirect effects of caffeine, such as those on blood flow, and to 
further address the mechanisms of the enhancement, we applied caffeine directly to 
hippocampal slices and found that even a brief exposure induced an immediate and lasting 
facilitation of CA2 responses (juvenile slices, Fig. 2a; adult slices, Supplementary Fig. 1a,c). 
Similar results were not observed in CA1. To better assess the persistence of the facilitation, 
slices were exposed to caffeine for 5-min and then returned to a holding chamber for either 
one, two or three hours prior to whole-cell recordings. Synaptic responses were enhanced for 
at least three hours post-treatment (Fig. 2b). We attribute the caffeine-induced potentiation 
in CA2 to blockade of A1Rs because other, more selective, A1R antagonists, such as 
DPCPX (10 nM; juvenile, Fig. 2c; adult, Supplementary Fig. 1b,d), PSB 36 (10 nM; not 
shown) or CPT (100 nM, Fig. 2h), induced a similar potentiation (hereafter termed A1R-P). 
As with caffeine, DPCPX failed to induce lasting effects on transmission in CA1 or CA3 
(CA1, black circles, Fig. 2c and Supplementary Fig. 1b,d; CA3, open circles, Supplementary 
Fig. 1e,f), but both caffeine and CPT can indeed potentiate responses in CA1 if the 
concentrations applied are significantly higher, as shown previously8 (caffeine 300 µM, Fig. 
2e,g; CPT 1 µM, Fig. 2f,h). These findings suggest that when low concentrations of A1R 
antagonists are used, enhancement is observed only in CA2.
Phosphodiesterases (PDEs) can be inhibited by caffeine, albeit at much higher doses than 
used here9, so we tested whether a broad-spectrum PDE inhibitor would mimic the effects 
observed with caffeine. It did not, indicating that caffeine’s actions were not likely the result 
of preferential PDE inhibition in CA2 (Supplementary Fig. 2a). A1Rs acting presynaptically 
are similarly unlikely to account for A1R-P in CA2: differences in paired-pulse facilitation 
in CA2 during DPCPX application differed little from effects observed in CA12,10 (not 
shown), consistent with the finding that A1R immunoreactivity in CA2 does not co-localize 
with presynaptic markers3. Additionally, blockade of GABAA-mediated transmission or 
performing experiments at 32 °C did not impact the magnitude of A1R-P induced by 
caffeine or DPCPX in CA2 (not shown).
To investigate further the mechanisms underlying A1R-P at CA2 synapses (Fig. 3a), we 
tested whether A1R-P shared properties with tetanus-induced LTP. A1R-P did not require 
synaptic stimulation during drug application, nor was it sensitive to the NMDAR antagonist 
AP5 or intracellular calcium chelation with BAPTA (Fig. 3b,c). Inhibition of CaMKII, PKC 
and PKM or PI3 kinase with KN62 (Fig. 3c), Go6983 (500 nM; not shown) or Wortmannin 
(100 nM; not shown), respectively, was also ineffective at blocking A1R-P. These data 
indicate that the calcium-dependent mechanisms required for LTP induction in CA1 are 
either bypassed or are unnecessary in A1R-P in CA2. They also argue against a critical role 
for ryanodine receptor-mediated increases in postsynaptic calcium11.
In agreement with A1Rs being coupled to the Gi/o family of G-proteins, which, when 
activated, inhibit adenylyl cyclases, several variants of adenylyl cyclase are highly enriched 
in CA2 (Supplementary Fig. 2b). Thus as might be expected, A1R-P was blocked by loading 
CA2 neurons with inhibitors of adenylyl cyclase or PKA (SQ22536 or PKI, respectively; 
Fig. 3e,f; 10 µM MDL-12,330A or 1 µM KT 5720, respectively, not shown). Bath 
application of U0126, a specific inhibitor for MEK (or the ERK inhibitor FR 180204, 2 µM, 
not shown) blocked the stabilization of A1R-P, but not its earliest phase (Fig. 3d), 
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suggesting a possible role of the Ras-MAPK pathway in A1R-P consolidation. Additionally, 
the DPCPX-mediated potentiation of synaptic responses in CA2 is correlated with an 
increase in the volume of spines located on the branches of secondary and tertiary apical 
dendrites in CA2 neurons (Supplementary Fig. 2c–e). Together, these findings indicate that 
induction of A1R-P in CA2 neurons is postsynaptic and is mediated through cAMP-
dependent activation of PKA. ERK-MAP kinase is likely required for its consolidation.
Adenosine in the brain is thought to rise throughout the day and be cleared during sleep2. 
Our results support the hypothesis that the use of caffeine provides temporary increases in 
mental acuity by blocking the normal inhibitory effects of adenosine. The role of CA2 in 
brain function is unknown, but clues may be gleaned by the finding that the number of non-
pyramidal (inhibitory) neurons are reduced in the CA2 of patients with schizophrenia12 and 
that caffeine has been observed to worsen symptoms of psychosis13. Interestingly, knockout 
of a vasopressin receptor enriched in CA2 produces mice with impairments in social 
recognition memory14 and caffeine enhances this kind of memory in rodents15. Thus, the 
robust potentiation induced by caffeine exposure both in vivo and in vitro strongly 
implicates A1R-P in CA2 as the physiological substrate for the cognitive enhancement 
provided by caffeine consumption.
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Figure 1. Orally-administered caffeine potentiates synaptic responses in CA2
The placement of stimulating and recording electrodes in coronal slices is shown in the 
schematic diagrams for areas CA2 (a) and CA1 (b). Sample currents evoked by increasing 
stimulation intensity from single neurons in slices from rats dosed with 20 mg/kg caffeine or 
vehicle (CA2, c; CA1, d). EPSCs evoked by a range of stimulation intensities in slices 
following oral administration of caffeine are enhanced in CA2 relative to vehicle (e), but not 
in CA1 (f). Note: bars indicate mean ± SEM in this and subsequent figures, and experiments 
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were approved by the NIEHS Animal Care and Use Committee. No change in the intrinsic 
excitability of CA2 neurons was detected at any dose of caffeine (g–i).
Simons et al. Page 5









Figure 2. A1R antagonists induce a long-lasting increase in synaptic strength in CA2 neurons in 
vitro
Bath-application of caffeine (100 µM, a) or DPCPX (10 nM, c) for 5-min potentiates EPSCs 
in CA2, but not in CA1. Duration of drug perfusion is indicated by the gray bar in (a) and 
(c) and in subsequent panels. Inset traces recorded at the time-points marked by the numbers 
(calibration; 25 pA, 25 msec). The A1R-P in CA2, plotted as a function of stimulation 
intensity, persists in slices previously exposed to caffeine (b) or DPCPX (d) for 5-min and 
then returned to standard ACSF for either one, two or three hours prior to recording. A high 
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concentration of caffeine potentiates responses in CA1 (300 µM, e and g). Similarly, The 
selectivity of the A1R antagonist CPT to potentiate responses in CA2 and not in CA1 is lost 
when a higher concentration is applied (100 nM versus 1 µM; f and h).
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Figure 3. A1R-potentiation at CA2 synapses is mediated by cAMP-dependent activation of PKA
A schematic overview of a likely mechanism for A1R-P in CA2 (a). Attempts to induce 
A1R-P in CA2 neurons were made using DPCPX (10 nM, 5-min, gray bar, b–f), and open 
circles, where present, show the DPCPX response in the absence of any other manipulation. 
A temporary pause in delivery of test stimulation at the start of DPCPX application (black 
circles; b) or bath application of AP5 (50 µM, blue circles; b) fails to block A1R-P. Loading 
cells with BAPTA (10 mM, green circles) or bath application of the CaMKII inhibitor KN62 
(10 µM, open triangles) also fails to block A1R-P (c). Although the MEK inhibitor U0126 
did not block induction of A1R-P (500 nM, red circles; d), it did block its consolidation. 
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Loading cells with the adenylyl cyclase inhibitor SQ22536 (100 µM, orange circles; e) or the 
PKA inhibitor PKI (1 µM, purple circles; f) blocks A1R-P in CA2.
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